Synthesis, spectral characterization, SC-XRD, HSA, DFT and catalytic activity of a dioxidomolybdenum complex with aminosalicyl-hydrazone Schiff base ligand: An experimental and theoretical approach

Synthesis, characterization, Hirshfeld surface analysis, antioxidant and selective β-glucuronidase inhibitory studies of transition metal complexes of hydrazide based Schiff base ligand

The synthesis of N'-[(4-hydroxy-3-methoxyphenyl)methylidene] 2-aminobenzohydrazide (H-AHMB) was performed by condensing O-vanillin with 2-aminobenzohydrazide and was characterized by FTIR, high resolution ESI(+) mass spectral analysis, 1H and 13C-NMR. The compound H-AHMB was crystallized in orthorhombic Pbca space group and studied for single crystal diffraction analysis. Hirshfeld surface analysis was also carried out for identifying short interatomic interactions. The major interactions H…H, O…H and C…H cover the Hirshfeld surface of H-AHMB. The metal complexes [M(AHMB)n] where M = Co(II), Ni(II), Cu(II) and Zn(II) were prepared from metal chlorides and H-AHMB ligand. The bonding was unambigously assigned using FTIR and UV/vis analysis. The synthesized ligand H-AHMB and its metal complexes were studied for β-glucuronidase enzyme inhibition. Surprisingly the metal complexes were found more active than the parent ligand and even the standard drug. Zn-AHMB shown IC50 = 17.3 ± 0.68 µM compared to IC50 = 45.75 ± 2.16 µM shown by D-saccharic acid-1,4-lactone used as standard. The better activity by Zn-AHMB implying zinc based metallodrug for the treatment of diseases associated with β-glucuronidase enzyme. The DPPH radical scavenging activities were also studied for all the synthesized compounds. The Co-AHMB complex with IC50 = 98.2 ± 1.78 µM was the only candidate to scavenge the DPPH free radicals.

Investigation of antituberculosis, antimicrobial, anti-inflammatory efficacies of newly synthesized transition metal(II) complexes of hydrazone ligands: structural elucidation and theoretical studies

Tuberculosis disease is a serious threat to humans and spreading quickly worldwide, therefore, to find a potent drug, the synthesis of hydrazone ligands endowed Co(II), Ni(II), Cu(II), Zn(II) metal complexes were carried out and well characterized by numerous spectral and analytical techniques. The octahedral geometry of the complexes was confirmed by spectral analysis. Further, in vitro antituberculosis efficacy of the compounds (1-10) revealed that complexes (6), (9), (10) have highest potency to control TB malformation with 0.0028 ± 0.0013-0.0063 ± 0.0013 µmol/mL MIC value while Zn(II) complex (10) (0.0028 ± 0.0013 µmol/mL) has nearly four time potent to suppress TB disease in comparison of streptomycin (0.0107 ± 0.0011 µmol/mL). The antimicrobial and anti-inflammatory evaluations revealed that the complex (10) is more active with lowest MIC (0.0057-0.0114 µmol/mL) and IC50 (7.14 ± 0.05 µM) values, correspondingly which are comparable with their respective standard drugs. Furthermore, the theoretical studies such as molecular docking, DFT, MESP and ADMET were employed to authenticate the potency of HL2 hydrazone ligand (2) and its metal complexes (7-10) which revealed that the zinc(II) complex (10) might be utilized as novel drug candidate for tuberculosis dysfunctions. So, the present research gives a new insight for in vivo investigation of the compounds.

Counter Anion Effects on the Formation and Structural Transformations of Mo(vi)-Hydrazone Coordination Assemblies: Salts, Solvates, Co-Crystals, and Neutral Complexes

Complex salts [1H]X and [1H](XA)0.5·2MeOH, and co-crystals [1H]X·0.5VA (X = chloride or bromide, XA = chloranilate or bromanilate, VA = o-vanillin azine), comprising [MoO2(HL)(MeOH)]+ ([1H]+) cation (H2L = 3-methoxysalicylaldehyde isonicotinoyl hydrazone), were prepared either by solution-based synthesis or by mechanochemical synthesis. Whereas [1H]X salts were extremely sensitive to humidity, their stability could be reinforced by the azine incorporation into the complex network. Solvent-mediated transformations of [1H]X led to methanol co-ligand replacement and afforded complexes [MoO2(HL)X] (2Cl·MeOH, 2Cl, and 2Br·0.5MeCN). However, solvates [1H](XA)0.5·2MeOH, under the same conditions, gave stable complexes [1H](XA)0.5 in which methanol remained coordinated. The differences in the assembly’s behavior were attributed to the packing arrangements, the relative orientation of cations and anions, and interactions between them. Polymorph [MoO2(L)(MeOH)] (1), not attainable by other routes, was the only product when compounds [MoO2(HL)X] were treated with a weak base at low temperatures. Tetranuclear [MoO2(L)]4 and polynuclear [MoO2(L)]n (2) supramolecular isomers, concomitantly crystallized when the reaction was conducted solvothermally. All of the complexes were characterized using X-ray diffraction methods (SCXRD and PXRD), spectroscopic methods (ATR-IR and solution-state and solid-state MAS NMR), and elemental and thermal analyses. The cytotoxicity of the different types of compounds against THP-1 and HepG2 cells was also evaluated.